Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

NuVasive, Inc. - Common Stock (NQ:NUVA)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about NuVasive, Inc. - Common Stock

< Previous 1 2 3 Next >
Tilray To Crater Over 30%? Here Are 5 Other Price Target Changes For Friday
Barclays cut Tilray Inc (NASDAQ: TLRY) price target from $4.5 to $2. Barclays analyst Gaurav Jain maintained an Underweight rating on the stock. Tilray Brands shares rose 0.3% to $2.87 in pre-market... 
Via Benzinga
Twitter, Zoom Video And Some Other Big Stocks Moving Lower On Tuesday
  GigaCloud Technology Inc. (NASDAQ: GCT) fell 29.9% to $29.01 after declining around 14% on Monday. 
Via Benzinga
NuVasive Earnings Perspective: Return On Invested Capital
According to Benzinga Pro, during Q1, NuVasive (NASDAQ:NUVA) earned $19.20 million, a 152.27% increase from the preceding quarter. NuVasive's sales decreased to $290.76 million, a 3.75% change since... 
Via Benzinga
4 Analysts Have This to Say About NuVasive
Analysts have provided the following ratings for NuVasive (NASDAQ:NUVA) within the last quarter: 
Via Benzinga
NuVasive: Q1 Earnings Insights
NuVasive (NASDAQ:NUVA) reported its Q1 earnings results on Wednesday, May 4, 2022 at 05:10 PM. Here's what investors need to know about the announcement. Earnings NuVasive beat estimated earnings by... 
Via Benzinga
Where NuVasive Stands With Analysts
NuVasive (NASDAQ:NUVA) has observed the following analyst ratings within th... 
Via Benzinga
Earnings Scheduled For July 28, 2021
Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.55 per share on revenue of $7.90 billion. • United... 
Via Benzinga
Earnings Scheduled For May 5, 2021
Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter. • EyePoint Pharmaceuticals (NASDAQ:EYPT... 
Via Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... 
Via Benzinga
Exposures Product Safety
Earnings Outlook For NuVasive
NuVasive (NASDAQ:NUVA) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that NuVasive will... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 28, 2022
Upgrades 
Via Benzinga
Health Care Stocks Could Use A Surgical Boom — Will It Happen For Stryker, Boston Scientific, Others?
Elective procedures are recovering slowly as Covid cases decline. Will they ever boom? 
Via Investor's Business Daily
NuVasive: Q4 Earnings Insights
NuVasive (NASDAQ:NUVA) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Kodiak's Wet AMD Treatment KSI-301 Did Not Meet Primary Endpoint In Phase... 
Via Benzinga
Why Did BofA Securities Give Globus Medical A Double Upgrade?
Enabling tech is likely to continue driving Globus Medical Inc’s (NYSE: 
Via Benzinga
NuVasive's Q3 Earnings Hit By COVID-19, Staff Shortage; Cuts FY21 Guidance
NuVasive Inc (NASDAQ: NUVA) reported Q3 net sales of $270.8 million, an 8.3% decrease on a reported and constant currency basis, missing the consensus of $291.79... 
Via Benzinga
Exposures COVID-19
Earnings Scheduled For February 23, 2022
Companies Reporting Before The Bell • Sapiens Intl Corp (NASDAQ:SPNS) is likely to report earnings for its fourth quarter. • Plymouth Industrial REIT (NYSE:PLYM)... 
Via Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front... 
Via Benzinga
NuVasive, Inc (NUVA) Q3 2021 Earnings Call Transcript
NUVA earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021
Upgrades According to JP Morgan, the prior rating for Arconic Corp (NYSE: 
Via Benzinga
NuVasive: Q3 Earnings Insights
NuVasive (NASDAQ:NUVA) reported its Q3 earnings results on Tuesday, November 9, 2021 at 04:00 PM. Here's what investors need to know about the announcement. Earnings NuVasive... 
Via Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Itamar Medical (NASDAQ:ITMR) shares moved upwards by 44.37% to $29.8 during Monday's pre-market session. The market value of their outstanding shares is at $... 
Via Benzinga
This Revolutionary Medical Device Company Goes to 11
To stand tall against a competitive market, NuVasive depends on a strong spinal platform. 
Via The Motley Fool
Exposures COVID-19
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges... 
Via Benzinga
NuVasive, inc (NUVA) Q2 2021 Earnings Call Transcript
NUVA earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
FDA Flags Certain Biocompatibility Concerns For NuVasive's Orthopedics' Precice Devices
The FDA informed healthcare providers of potential biocompatibility concerns with NuVasive Inc's (NASDAQ: 
Via Benzinga
Exposures Product Safety
NuVasive Inc (NUVA) Q1 2021 Earnings Call Transcript
NUVA earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.